These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-000086-35 A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with ... bad-data
Completed, but no date, and reported results 2004-000087-27 A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen with ... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000088-92 A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of Recombinant Factor VIIa (NovoSeven®/Niastase®) with Brain Contusi... 2006-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000100-40 A Multicentre, randomised, double-blind, placebo controlled, dose escalation trial on safety and efficacy of activated recombinant factor VII (rFVIIa/NovoSeven) in the treatment of post-operative blee... 2007-11-29 bad-data
Completed, but no date, and reported results 2004-000514-38 4T study Treating to Target in Type 2 Diabetes A 36-month, Multi-centre, Open-label, Randomised, Parallel-group Trial Comparing the Safety, Efficacy and Durability of Adding a Basal Insulin versus a T... bad-data
Ongoing, reported early 2004-001461-18 A 20 week multi-national, open-labelled, randomised, three-group parallel trial comparing administration of insulin detemir morning, insulin detemir evening and NPH insulin evening as add-on to oral a... not-yet-due
Exempt, with results 2004-001692-19 A single-centre, randomised, double-blind, cross-over trial comparing the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents... 2005-10-09 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-002778-50 A multi-national, open labelled, randomised, stratified, parallel group 36 week comparison of twice daily Biphasic Insulin Aspart 30 versus thrice daily Biphasic Insulin Aspart 50 and 70 all in combin... 2006-03-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004202-24 Randomised, Double-blind, Placebo-Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven/Niastase) in Acute Intra-Cerebral Haem... 2007-01-31 bad-data
Completed, but no date, and reported results 2005-000042-37 Norditropin Treatment in Subjects with Noonan Syndrome. Effects on Linear Growth and Final Height - Data Collection and Follow-up Visit bad-data
Reported results 2005-000319-87 A 52 week, Open Labelled, Randomised multi-centre 2 Arm Parallel Group Trial comparing Efficacy and Safety of Insulin Aspart, given in a Fixed Dose Regimen or in a Flexible Regimen, with or without In... 2006-11-20 due-trials
Exempt, with results 2005-000891-42 A randomised, open-label, multi-centre trial investigating the intra-subject variability of ROTEM® and TEG® parameters following two intravenous administrations of the same dose of activated recombina... 2006-05-16 not-yet-due
Ongoing, reported early 2005-000976-42 A multi-centre, open-labelled, randomised, two-group parallel, treat-to-target trial comparing the weight change in overweight and obese subjects with type 2 diabetes after 26 weeks of treatment with ... not-yet-due
Completed, but no date, and reported results 2005-001522-88 A four-month open-labelled randomised multi-centre two-group parallel trial comparing administration of insulin detemir once or twice daily in a basal-bolus regimen with insulin aspart in subjects wit... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002059-41 A multi-center, randomized, double-blind, parallel group, placebo controlled trial to evaluate the efficacy and safety of activated recombinant factor VII rFVIIa/NovoSeven/NiaStase in severely injur... 2008-11-09 bad-data
Reported results 2005-003414-15 Liraglutide Effect and Action in Diabetes LEAD-1 Effect on glycaemic control after once daily administration of liraglutide in combination with glimepiride versus glimepiride monotherapy versus ... 2007-06-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003415-71 Liraglutide Effect and Action in Diabetes (LEAD-5): Effects on glycaemic control after once daily administration of liraglutide in combination with glimepiride and metformin versus glimepiride and met... 2007-05-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003417-32 Efecto y acción de liraglutida en diabetes (LEAD-2): Efecto sobre el control glucémico tras la administración una vez al día de liraglutida en combinación con metformina frente a metformina en monoter... 2009-02-13 bad-data
Reported results 2005-003980-21 A Multinational, Open Label, Randomised, Three Period, Cross Over Trial Investigating The Impact Of Exercise And Type Of Basal Insulin Used On Blood Glucose Levels In Subjects With Type 1 Diabetes Tre... 2006-11-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005378-58 Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes: A 104-week, open-label, multicentre, randomised trial followed by 12-week re-randomised extension ... 2008-06-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000051-18 A 52-Week, Multinational, Multi-Centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Detemir and NPH Insulin in Children and Adolescents 2-16 years with Type 1 Diabet... 2009-04-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000796-15 Inhaled pre-prandial human insulin with the AERx® iDMS plus metformin versus rosiglitazone plus metformin in type 2 diabetes: a 26-week, open-label, multicentre, randomised, parallel trial to investig... 2008-03-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001629-24 A 12 month, open-label, multi-center trial to investigate the endometrial safety of Vagifem Low Dose (10ug 17beta-estradiol vaginal tablet) in postmenopausal women with atrophic vaginitis symptoms. Tr... 2008-11-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002478-23 A 52-Week, Multinational, Multi-Centre, Open-Labelled Extension Trial of Insulin Detemir in Children and Adolescents 3-17 years with Type 1 Diabetes on a Basal- Bolus Regimen with Insulin Aspart as Bo... 2009-09-07 bad-data
Completed, but no date, and reported results Terminated 2006-003060-59 A 32 week, national, single-centre, open-labelled, randomised, cross-over trial comparing energy expenditure with insulin detemir versus NPH insulin using a basal-bolus regimen with insulin aspart as ... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003148-51 A Multi-Centre, Open-Label, Single-Arm and Multiple Dosing Trial on Efficacy and Safety of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Subjects with Congenital Factor XIII Def... 2010-04-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003288-29 A multi-national, open-labelled, randomised, parallel group, 4 week run-in and 26 weeks treat-to-target comparison of biphasic insulin aspart 30 once daily versus insulin glargine once daily both in c... 2008-04-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004481-13 Efecto de liraglutida sobre el peso corporal en sujetos obesos sin diabetes Ensayo de 20 semanas de duración, aleatorizado, doble ciego, controlado con placebo, en seis grupos paralelos, multicéntrico... 2009-04-30 bad-data
Completed, but no date, and reported results Terminated 2006-004622-81 Inhaled preprandial human insulin with the AERx® iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and asthma: a 52-week, open-label, multinational, randomised, parallel trial... bad-data
Ongoing, reported early 2006-004623-12 Inhaled human insulin with the AERx® iDMS as prandial monotherapy compared to combination therapy with metformin and glimepiride in type 2 diabetes: an eighteen-week, open-label, multicentre, randomis... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-004702-56 Outcome Trial Evaluating the Efficacy and Safety of Norditropin® in Adult Patients on Chronic Haemodialysis A Randomised, Double-blind, Parallel group, placebo controlled, Multi-centre trial 2009-12-19 bad-data
Completed, but no date, and reported results Terminated 2006-004731-29 Inhaled preprandial human insulin with the AERx® iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and chronic obstructive pulmonary disease: A 52-week, open-label, multicentr... bad-data
Reported results 2006-004733-15 A 12-months multi-national, multi-centre, double-blind, randomised, parallel safety and efficacy comparison of insulin detemir produced by the current process and insulin detemir produced by the NN729... 2008-07-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004861-33 A randomised, parallel-group, open-labelled, multinational trial comparing the efficacy and safety of insulin detemir (Levemir®) versus human insulin (NPH insulin), used in combination with insulin as... 2010-08-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004879-35 A multi-centre, randomised, double-blinded, controlled, dose-escalation trial on safety and efficacy of activated recombinant FVII analogue (NN1731) in the treatment of joint bleeds in congenital haem... 2009-10-23 bad-data
Reported results 2006-005350-79 A single arm, single-centre, open-label, exploratory trial of recombinant Interleukin-21 administered subcutaneously for 4 weeks as neo-adjuvant treatment prior to sentinel lymph node/complete lymph n... 2008-06-25 due-trials
Exempt, with results Terminated 2006-005751-16 An open label, dose escalation safety and tolerability trial of the combination of s.c. recombinant human IL-21 (rIL-21) and sunitinib (phase 1) followed by an open label stratified randomized 2-arm t... 2008-06-30 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006092-21 Efecto y acción de liraglutida en diabetes (LEAD-6): efecto sobre el control glucémico de liraglutida o exenatida en combinación con metformina, sulfonilurea o ambas en sujetos con diabetes tipo 2. En... 2009-04-14 bad-data
Ongoing, reported early 2006-006589-41 Levemir® in ageing patients with type 2 diabetes not-yet-due
Ongoing, reported early 2006-006715-77 A randomised, multicentric, open labelled, parallel group trial with insulin aspart and insulin detemir, investigating the glycaemic effect and profile in children with Type 1 diabetes, of two separ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000123-18 A randomised, controlled, parallel, open-labelled, multinational, trial comparing the efficacy and safety of step-wise addition of insulin aspart according to the largest meals (Basic Basal Plus regim... 2009-05-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001506-25 An open–label Phase 2 Trial of Pegylated Liposomal Doxorubicin and rIL-21 in Ovarian Cancer Patients with Persistent or Progressive Disease after, or Relapse within One Year of, Completion of Standard... 2008-09-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002462-35 A 16 week randomised, open labelled, 3-armed, parallel group, treat-to-target trial comparing twice daily (BID) injections of SIAC 30 (B), SIAC 45 (B) and NovoMix® 30, all in combination with metform... 2008-08-28 bad-data
Reported results 2007-002474-60 A 16 week randomised, open labelled, 3-armed, treat-to-target, parallel group trial comparing SIBA (D) once daily + NovoRapid®, SIBA (E) once daily + NovoRapid® and insulin glargine once daily + NovoR... 2008-06-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002476-33 A 16 week randomised, open labelled, 3 armed, parallel group, treat-to-target trial comparing once daily injection of SIAC 30 (B), SIAC 45 (B) and insulin glargine, all in combination with metformin i... 2008-08-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003937-17 Efecto de liraglutida en comparación con sitagliptina, ambas en combinación con metformina en sujetos con diabetes tipo 2. Ensayo de 26 semanas, aleatorizado, abierto, con comparador activo, de tres g... 2010-06-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003956-12 Investigation of safety and efficacy of five doses of NNC 0113-0217 versus placebo and open-label liraglutide, as add on therapy, in subjects diagnosed with type 2 diabetes currently treated with metf... 2009-02-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005317-19 Efecto de insulina detemir en combinación con liraglutida y metformina en comparación con liraglutida y metformina en sujetos con diabetes tipo 2. Ensayo de 26 semanas, aleatorizado, abierto, de grupo... 2010-11-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001049-24 Efecto de liraglutida en el peso corporal en sujetos no diabéticos obesos o con sobrepeso y comorbilidad. Ensayo clínico aleatorizado, doble-ciego, controlado con placebo, grupos paralelos, multicéntr... 2015-06-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001050-40 A 26 week randomised, open labelled, parallel group, multi-national, treat-to-target trial comparing efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin ver... 2009-08-28 bad-data
Completed, but no date, and reported results 2008-001061-29 A randomised, double blind, placebo-controlled, multiple dose, dose-escalating, sequential dose group trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics of pegylated long-... bad-data
Reported results 2008-001674-32 NordiNet International Outcome Study (NordiNet IOS) 2016-12-31 due-trials
Exempt, with results 2008-002157-21 A Multi-Centre, Multi-National, Open-Label Sequential Trial Comparing Pharmacokinetics and Safety of N8 and Advate in Subjects with Haemophilia A 2009-10-01 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-002199-88 Efecto de liraglutida en el peso corporal en sujetos con sobrepeso u obesos con diabetes tipo 2. Ensayo clínico de 1 año de duración, aleatorizado, doble-ciego, controlado con placebo, con tres grupos... 2013-01-25 bad-data
Ongoing, reported early 2008-003739-19 Ensayo multicéntrico, abierto, aleatorizado, de dos grupos, paralelo para comparar el cambio en la distribución de grasa en sujetos con sobrepeso y obesos con diabetes tipo 2 tras 26 semanas de tratam... not-yet-due
Reported results 2008-003960-20 A Multi-Centre, Open-Label, Non-Controlled Trial on Safety and Efficacy of N8 in Prevention and Treatment of Bleeds in Previously Treated Subjects with Haemophilia A Sub-Trial: Safety and Efficacy of ... 2011-09-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005767-34 A trial comparing efficacy and safety of NN5401 with insulin glargine, both in combination with oral antidiabetic drugs in subjects with type 2 diabetes 2010-10-25 bad-data
Reported results 2008-005768-15 A 26-week, randomised, open-labelled, two-arm, parallel-group, treat-to-target trial comparing efficacy and safety of soluble insulin analogue combination (SIAC) twice daily (BID) with biphasic insuli... 2010-08-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005769-71 A 26-week, multinational, multi-centre, open-labelled, two-arm, parallel, randomised, treat-to-target trial comparing efficacy and safety of soluble insulin analogue combination (SIAC) once daily plus... 2010-05-31 bad-data
Reported results 2008-005771-10 A 26 week randomised, controlled, open label, multicentre, multinational, three-arm, treat to target trial comparing efficacy and safety of three different dosing regimens of either Soluble Insulin Ba... 2010-09-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005774-13 A 52 week randomised, controlled, open label, multicentre, multinational, parallel, treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a b... 2010-12-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005776-27 A 52-week randomised, controlled, open label, multicentre, multinational treat-to-target trial comparing the efficacy and safety of SIBA and insulin glargine, both injected once daily in combination w... 2011-01-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005777-35 A 52-week randomised, controlled, open label, multicentre, multinational treat-to-target trial comparing efficacy and safety of SIBA and insulin glargine both administered once daily in a basal-bol... 2010-11-05 bad-data
Reported results 2008-005945-46 Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects with Haemophilia A 2016-06-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006324-62 A Multi-Centre, Randomised, Double-Blind, Placebo Controlled Trial on Efficacy and Safety of FXIII Replenishment with two different Doses of Recombinant Factor XIII following Cardiopulmonary Bypass S... 2011-02-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006424-54 An Exploratory Multi-Centre, Multi-National, Randomised, Double Blinded, Parallel Arm Trial Evaluating Safety, Pharmacokinetics and Dose-finding of prophylactic administration of Long Acting rFVIIa (L... 2011-03-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-007883-41 A Multi-Centre, Open-Label, Single-Arm, and Multiple Dosing Trial on Safety of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Subjects with Congenital Factor XIII Deficiency 2015-10-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008240-25 A randomised, open-labelled, single dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics of pegylated long-acting human growth hormone (NNC126-0083) co... 2010-07-18 bad-data
Exempt, with results 2008-008306-43 A Trial Investigating the Pharmacokinetic Properties of NN1250 in Children, Adolescents and Adults with Type 1 Diabetes 2010-05-03 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-010662-28 A trial comparing efficacy and safety of NN1250 and insulin glargine in subjects with type 2 diabetes 2010-11-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-011271-78 A trial comparing efficacy and safety of NN5401 with insulin glargine in insulin naive subjects with type 2 diabetes 2010-10-26 bad-data
Reported results 2009-011398-33 BEGIN™: EASY AM 2010-11-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011399-31 BEGIN™: EASY PM 2010-12-01 bad-data
Reported results 2009-011672-29 A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen 2011-01-10 due-trials
Reported results 2009-011791-30 A randomised, double-blind, placebo-controlled, multiple dose trial of NNC 0151-0000-0000 in subjects with rheumatoid arthritis 2013-02-06 due-trials
Reported results 2009-012201-19 LEADER (ES): Efecto y acción de laliraglutida en la diabetes: evaluación de los resultados de criterios de valoración cardiovasculares. Estudio a largo plazo, multicéntrico, internacional, aleatorizad... 2015-12-17 due-trials
Reported results 2009-012923-27 Begin™: Flex T1. A 26-week trial investigating the dosing flexibility, efficacy and safety of NN1250 in subjects with type 1 diabetes with a 26-week extension. 2011-05-23 due-trials
Reported results Terminated 2009-013090-18 A 52-Week Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Multinational Exploratory Trial In Islet Cell Transplant Subjects With Type 1 Diabetes Mellitus To Evaluate The Ea... 2013-05-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-013412-13 An extension trial comparing safety and efficacy of NN5401 plus meal-time insulin aspart for the remaining meals with insulin detemir plus meal-time insulin aspart in type 1 diabetes 2010-12-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014894-42 A 26-week randomised, controlled, open label, multicentre, multinational, treat to target trial investigating the impact of dietary intervention on weight change and the relationship between weight ch... 2011-11-14 bad-data
Reported results 2009-015721-36 An extension trial to NN1250-3585 investigating safety and efficacy of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen 2011-06-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015754-38 An extension trial to NN1250-3579 comparing safety and efficacy of NN1250 plus OAD(s) with insulin glargine plus OAD(s) in type 2 diabetes 2011-12-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015755-24 An extension trial to trial NN1250-3583 comparing safety and efficacy of NN1250 with insulin glargine, both with insulin aspart as meal-time insulin, in type 1 diabetes 2011-12-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015816-17 An extension trial to NN1250-3582 comparing safety and efficacy of NN1250 and insulin glargine, both with insulin aspart as meal-time insulin � OADs in type 2 diabetes 2011-05-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015839-33 An extension trial comparing safety and efficacy of NN5401 with insulin glargine in subjects with type 2 diabetes 2011-05-04 bad-data
Reported results 2009-016383-36 A Multi-Centre, Open-Label, Non-Controlled Trial on Safety and Efficacy of N8 in Previously Treated Paediatric Patients with Haemophilia A 2011-11-21 due-trials
Exempt, with results 2009-016779-31 A Trial Investigating the Pharmacokinetic Properties of NN5401 in Children, Adolescents and Adults with Type 1 Diabetes 2010-11-12 not-yet-due
Reported results 2009-016869-28 A Phase 3b Trial Investigating the Pharmacokinetics and Safety Profile of a Single Intravenous Dose of rFXIII in Paediatric (1 to less than 6 Years Old) Subjects with Congenital FXIII A-subunit Defici... 2011-10-07 due-trials
Ongoing, reported early 2009-017387-16 To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapy not-yet-due
Other 2009-017814-56 A 26-week, randomised, open-label, multinational, treat-to-target trial comparing efficacy and safety of insulin degludec/insulin aspart once daily (OD) and insulin glargine OD both in combination wit... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-018974-19 A randomised, controlled, open label, multicentre, multinational, treat-to-target trial investigating the efficacy and safety of intensification with addition of bolus insulin aspart in subjects with ... 2012-04-25 bad-data
Reported results 2010-019261-28 A randomised, single-dose, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy of NNC 0142-0000-0002 in subjects with active rheumatoid arthritis 2011-10-11 due-trials
Reported results 2010-020192-23 A Multi-Centre, Multinational, Open-Label, Single-Arm and Multiple Dosing Trial on Safety and Efficacy of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Paediatric Subjects with ... 2015-03-29 due-trials
Reported results 2010-020836-21 A randomised, double-blind, parallel-group, placebo-controlled, induction trial to assess the clinical efficacy and safety of NNC0142-0000-0002 in subjects with moderately to severely active Crohn’s d... 2013-05-23 due-trials
Exempt, with results 2010-021057-39 A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety/Tolerability, Pharmacokinetics & Pharmacodynamics of Liraglutide in Paediatric (10 – 17 years old) and Adult Subjects with Type 2 ... 2011-09-30 not-yet-due
Reported results 2010-021283-14 A randomised, double blind, placebo-controlled, multiple dose trial of Anti-IL-20 (109-0012) in subjects with rheumatoid arthritis 2012-03-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021560-15 A 26 week randomised, parallel three-arm, open-label, multi-centre, multinational treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide versus insulin degludec or... 2012-11-22 bad-data
Ongoing 2010-022304-50 A trial comparing the efficacy and safety of insulin degludec three times weekly in insulin naïve subjects with type 2 diabetes mellitus when titrated using two different titration algorithms not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022337-29 A trial comparing the efficacy and safety of insulin degludec once daily in insulin naïve subjects with type 2 diabetes mellitus when titrated using two different titration algorithms 2011-12-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023069-24 A Multi-centre, Single-blind Trial Evaluating Safety and Efficacy, including Pharmacokinetics, of NNC 0156 0000 0009 when used for Treatment and Prophylaxis of Bleeding Episodes in Patients with Haemo... 2013-05-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023070-40 An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B 2013-12-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023072-17 Safety and Efficacy of NNC-0156-0000-0009 after Long-Term Exposure in Patients with Haemophilia B 2014-03-31 bad-data
Reported results 2010-023803-92 Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients with Congenital Haemophilia and Inhibitors 2012-08-13 due-trials
Exempt, with results 2010-023921-39 Multi-Centre, Open-Label, Randomised Trial Investigating the Pharmacokinetics of a Single Dose of NNC 0155-0000-0004 (N8) in Patients with Haemophilia A 2011-09-25 not-yet-due
Reported results 2010-024049-53 Efficacy and Safety of FIAsp compared to insulin aspart both in Combination with insulin detemir in Adults with Type 1 Diabetes 2015-06-11 due-trials
Reported results 2010-024051-93 Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination with Insulin Glargine and Metformin in Adults with Type 2 Diabetes 2015-01-22 due-trials
Reported results 2010-024054-11 Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart compared to NovoRapid® in Adults with Type 1 Diabetes 2017-07-21 due-trials
Reported results 2010-024303-27 A 20 weeks randomised, multinational, open labelled, 2 armed, parallel group comparison of twice daily subject-driven titration of biphasic insulin aspart (BIAsp) 30 versus twice daily investigator-dr... 2012-07-13 due-trials
Ongoing 2011-000826-31 Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children with Haemophilia B not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-001033-16 Safety and Efficacy of NNC 0155-0000-0004 in 2018-12-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001142-15 A Multi-national Trial Evaluating Safety and Efficacy, including Pharmacokinetics, of NNC 0129-0000-1003 (N8-GP) when Administered for Treatment and Prophylaxis of Bleeding in Patients with Haemophili... 2018-12-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001144-30 Efficacy and Safety of NNC 0129-0000-1003 (N8-GP) during Surgical Procedures in Patients with Haemophilia A 2018-12-10 bad-data
Reported results 2011-001493-25 A trial comparing the efficacy and safety of adding liraglutide versus addition of insulin aspart with the largest meal to insulin degludec, both in combination with metformin, in subjects with type 2... 2012-07-09 due-trials
Reported results 2011-001568-22 A multicenter, randomised, double-blind, placebo-controlled, multiple-dose trial with rFXIII administered to subjects with mild to moderate active ulcerative colitis 2013-07-10 due-trials
Reported results 2011-001712-61 A 26-week, randomised, open-label, multinational, treat-to-target trial comparing efficacy and safety of insulin degludec/insulin aspart (IDegAsp) twice daily (BID) and BIAsp 30 BID both with metformi... 2012-11-19 due-trials
Exempt, with results 2011-002104-32 A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetes not-yet-due
Reported results 2011-002336-72 A 26-weeks randomised, parallel two-arm, double-blind, multi-centre, multinational, treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide with insulin degludec in... 2012-10-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002605-29 Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycaemic control in children and adolescents with type 2 diabetes 2020-05-20 bad-data
Reported results 2011-002696-41 The effect of liraglutide versus placebo when added to basal insulin analogues with or without metformin in subjects with type 2 diabetes 2013-10-22 due-trials
Trial is outside EEC, and reported results 2011-002949-35 This trial is a randomized, single-centre, double-blind, two-period cross-over glucose clamp trial to test for bioequivalence between two SIBA (IDeg) formulations in healthy subjects. bad-data
Reported results 2011-002968-24 Efficacy and safety of liraglutide versus placebo as add-on to existing diabetes medication in subjects with type 2 diabetes and moderate renal impairment 2013-08-20 due-trials
Reported results 2011-003148-39 A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Detemir in children and adolescents 1 to less than 18 years ... 2013-07-30 due-trials
Reported results 2011-004665-32 The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensification 2014-02-14 due-trials
Reported results 2011-004930-33 A 24 week randomised, open label, 3 parallel-group 2013-10-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-005376-42 A randomised, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy of NNC0114-0006 in subjects with active rheumatoid arthritis 2013-08-26 bad-data
Reported results 2012-000038-20 A randomised, double-blind, placebo-controlled trial to assess safety, tolerability and pharmacokinetics of liraglutide in obese adolescent subjects aged 12 to 17 years 2014-05-26 due-trials
Reported results 2012-000140-97 The efficacy of insulin degludec/liraglutide as add-on therapy in controlling glycaemia in adults with type 2 diabetes inadequately controlled on sulphonylurea with or without metformin therapy 2013-10-23 due-trials
Reported results 2012-000209-63 The efficacy of insulin degludec/liraglutide in controlling glycaemia in adults with type 2 diabetes inadequately controlled on GLP-1 receptor agonist and metformin therapy 2014-03-11 due-trials
Reported results 2012-000373-23 A trial comparing the efficacy and safety of two different titration algorithms for insulin degludec/insulin aspart in subjects with type 2 diabetes mellitus previously treated with insulin glargine 2013-08-22 due-trials
Reported results 2012-000609-58 A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoid a... 2014-11-30 due-trials
Reported results 2012-000610-11 A randomised, double blind, placebo-controlled, multiple dose, phase 2b, 24 week trial followed by an open label extension of NNC0109-0012, an anti-IL-20 biologic, in patients with active rheumatoid a... 2014-08-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001711-23 A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients with Severe Haemophilia A 2018-09-28 bad-data
Reported results 2012-001930-32 A randomised, double blind, cross-over trial comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 diabetes 2016-01-12 due-trials
Reported results 2012-002346-20 A 26-week trial comparing efficacy and safety of insulin degludec/insulin aspart BID and insulin degludec OD plus insulin aspart in subjects with type 2 Diabetes Mellitus treated with basal insulin in... 2014-01-09 due-trials
Reported results 2012-002432-93 A randomised, double-blind, placebo-controlled, parallel-group trial to assess clinical efficacy and safety of NNC0114-0006 in subjects with active Crohn’s disease 2014-12-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002839-28 A long-term, randomised, double-blind, placebo-controlled, multinational, multi-centre trial to evaluate cardiovascular and other long-term outcomes with semaglutide in subjects with type 2 diabetes 2016-03-15 bad-data
Reported results 2012-003152-37 A randomised trial comparing efficacy and safety after 2014-03-07 due-trials
Reported results 2012-003566-41 A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insuli... 2014-11-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-003580-21 The efficacy and safety of liraglutide as adjunct therapy to insulin in the treatment of type 1 diabetes 2015-06-04 bad-data
Reported results 2012-004413-14 A trial comparing the efficacy and safety of insulin degludec/liraglutide versus insulin glargine in subjects with type 2 diabetes mellitus. 2014-11-04 due-trials
Reported results 2012-004625-25 A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) in subjects with type 2 diabetes mellitus using two different titration algorithms 2015-12-23 due-trials
Reported results 2012-004826-92 Efficacy and safety of semaglutide once-weekly versus exenatide ER 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes 2015-07-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004827-19 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin and/or TZD in subjects with type 2 diabetes 2015-11-26 bad-data
Ongoing 2012-004867-38 Safety and efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophila B. not-yet-due
Reported results 2012-004931-22 Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes not achieving adequate glycaemic control on sitagliptin and metformin 2015-06-15 due-trials
Reported results 2012-004984-27 Efficacy and safety of liraglutide versus lixisenatide as add-on to metformin in subjects with type 2 diabetes 2014-11-19 due-trials
Reported results 2012-004994-16 Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes 2015-01-09 due-trials
Reported results 2012-005583-10 Efficacy and safety of FIAsp in a basal-bolus regimen versus basal insulin therapy, both in combination with metformin in adult Subjects with type 2 diabetes 2014-11-17 due-trials
Reported results 2012-005778-74 The efficacy and safety of liraglutide adjunct to insulin treatment in type 1 diabetes. A 26 week randomised, insulin capped, placebo-controlled, double-blind, parallel group, multinational, multi-cen... 2016-01-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-000013-20 A randomised, open-labelled, active-controlled, multinational, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of long-acting growth ho... 2014-11-04 bad-data
Reported results 2013-000632-94 Efficacy and safety of semaglutide once-weekly versus placebo in drug-naïve subjects with type 2 diabetes 2015-05-13 due-trials
Reported results Terminated 2013-001492-20 A randomised, active comparator, double-blind, multi centre, parallel, phase 2a trial, investigating the mechanism of action of NNC0109-0012 (anti-IL-20 mAb) through synovial biopsies in subjects with... 2014-08-11 due-trials
Reported results 2013-002233-37 A 6-week randomised, double-blind, parallel-group trial evaluating compatibility and safety of FIAsp and insulin aspart with an external continuous subcutaneous insulin infusion system in adult subjec... 2014-05-12 due-trials
Reported results 2013-002371-17 A trial comparing cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events 2016-10-31 due-trials
Reported results 2013-002878-47 A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin deglud... 2015-04-28 due-trials
Reported results 2013-002892-16 A multicentre, multinational, randomised, parallel-group, placebo-controlled (double blind) and active-controlled (open) trial to compare the efficacy and safety of once weekly dosing of NNC0195-0092 ... 2018-05-07 due-trials
Other 2013-004025-88 Safety and Efficacy of turoctocog alfa pegol (N8-GP) in Previously Untreated Patients with Haemophilia A not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-004392-12 Efficacy and safety of semaglutide once weekly versus insulin glargine once daily as add on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes 2015-09-03 bad-data
Reported results 2013-004502-26 Efficacy and safety of semaglutide once-weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes 2015-11-21 due-trials
Trial is outside EEC, and reported results 2013-004791-35 Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated Chinese patients with haemophilia A bad-data
Reported results 2013-005500-33 A 26-week open label, randomised, 2-armed, parallel group, multi-centre trial investigating efficacy and safety of insulin detemir versus insulin Neutral Protamine Hagedorn in combination with metform... 2016-06-14 due-trials
Reported results 2014-000290-39 A multicentre, multinational, randomised, open-labelled, parallel-group, active-controlled trial to compare the safety of once weekly dosing of NNC0195-0092 with daily Norditropin® FlexPro® for 26 wee... 2016-01-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-001215-39 A randomised, double-blind, double-dummy, placebo-controlled, parallel-group multi-centre clinical proof-of-principle trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigatin... 2019-02-27 bad-data
Reported results 2014-001540-38 Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitus. 2017-04-12 due-trials
Reported results 2014-002568-33 Efficacy and Safety of Faster-acting Insulin Aspart compared to NovoRapid® both in Combination with Insulin Degludec in Children and Adolescents with Type 1 Diabetes 2018-03-05 due-trials
Reported results 2014-002716-16 An 8-week randomised, double-blind, parallel, multiple dose trial comparing NNC0123-0000-0338 in a tablet formulation and insulin glargine in subjects with type 2 diabetes currently treated with oral ... 2015-12-31 due-trials
Reported results 2014-003196-39 Dose-finding of semaglutide administered subcutaneously once daily versus placebo and liraglutide in subjects with type 2 diabetes. A 26-week, multicentre, double-blind, randomised, controlled dose-fi... 2016-10-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-003621-18 DUAL™VII - Insulin degludec/liraglutide (IDegLira) vs. basal-bolus therapy: A clinical trial comparing efficacy and safety of insulin degludec/liraglutide (IDegLira) versus basal-bolus therapy in subj... 2016-10-05 bad-data
Reported results 2014-003708-62 A 32-week randomised, multinational, treat-to-target, open label, parallel group comparison of stepwise insulin intensification of biphasic insulin aspart (BIAsp) 30 and basal-bolus therapy with insul... 2016-09-21 due-trials
Reported results 2014-004353-14 Effect of liraglutide for weight management in pubertal adolescent subjects with obesity. 56-week, double-blind, randomised, parallel-group, placebo-controlled multi-national trial followed by a 26-we... 2019-08-08 due-trials
Other 2014-004415-37 Effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome. A randomised, placebo controlled, parallel group, multi-centre, multinational trial with a 16-week double... not-yet-due
Trial is outside EEC, and reported results 2014-004454-34 A randomised, double-blind, placebo-controlled trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of liraglutide in obese children aged 7 to 11 years bad-data
Reported results 2014-005375-91 Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes 2017-05-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-005639-15 A 104 week clinical trial comparing long term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine therapy in subjects with type 2 diabetes mellitus 2018-10-03 bad-data
Ongoing 2015-000531-32 A randomised, multinational, active-controlled,(open-labelled), dose finding, (double-blinded), parallel group trial investigating efficacy and safety of once-weekly NNC0195-0092 treatment compared to... not-yet-due
Reported results 2015-001047-36 Efficacy and Safety of Faster-acting Insulin Aspart compared to NovoRapid® both in combination with Insulin Degludec in Adults with Type 1 Diabetes 2017-08-18 due-trials
Reported results 2015-001351-71 Efficacy and long-term safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes 2018-03-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2015-001596-48 A clinical trial comparing glycaemic control and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) as add-on therapy to SGLT2i in subjects with type 2 diabetes mellitus 2017-10-23 bad-data
Ongoing, reported early 2015-001919-13 Pharmacogenetic testing of saliva samples from patients with ≥5 exposure days to rFVIIa analogue in the adept™2 trial. not-yet-due
Reported results 2015-002417-29 Efficacy in controlling glycaemia with Victoza® (liraglutide) as add-on to metformin vs. OADs as add-on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes inadequately co... 2019-08-12 due-trials
Trial is outside EEC, and reported results 2015-002613-30 A 12-month, open-labelled, randomised, parallel-group, multi-centre, interventional trial to evaluate the efficacy and safety of recombinant human growth hormone (hGH) (Norditropin® Nordilet®) therapy... bad-data
Reported results 2015-003563-10 A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes 2018-09-25 due-trials
Completed, but no date, and reported results 2015-004768-12 A 38 week trial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or without oral... bad-data
Reported results 2015-005209-36 Efficacy and Safety of Oral Semaglutide versus Empagliflozin in Subjects with Type 2 Diabetes Mellitus. 2018-03-08 due-trials
Reported results 2015-005210-30 Efficacy and Safety of Oral Semaglutide versus Liraglutide and versus Placebo in Subjects with Type 2 Diabetes Mellitus. A 52-week randomised, double-blind, active- and placebo-controlled trial 2018-05-30 due-trials
Reported results 2015-005326-19 Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment. A 26-week randomised, double-blind, placebo-controlled trial 2018-05-15 due-trials
Exempt, with results 2015-005327-63 A multi-centre, comparative, double blind, randomised cross-over trial investigating single dose pharmacokinetics and safety of turoctocog alfa pegol from the pivotal process and turoctocog alfa pegol... 2017-04-07 not-yet-due
Reported results 2015-005593-38 Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes Mellitus. A 52 week Randomised, Open-label, Ac... 2019-03-27 due-trials
Reported results 2015-005619-33 Effect and safety of liraglutide 3.0 mg in subjects with overweight or obesity and type 2 diabetes mellitus treated with basal insulin 2018-09-25 due-trials
Reported results 2015-005622-19 Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes mellitus treated with diet and exercise only. A 26-week, randomised, double-blind, placebo-controlled trial 2017-12-08 due-trials
Listed as ongoing, but also has a completion date 2016-000510-30 A Multi-Centre, Randomised, Open-Label, Controlled Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients with Inhibitors 2020-01-31 bad-data
Listed as ongoing, but also has a completion date 2016-000614-29 A Multi-Centre Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients with Severe Haemophilia A without Inhibitors 2020-06-03 bad-data
Listed as ongoing, but also has a completion date 2016-000685-39 Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis A 72-week randomised, double-blind, place... 2020-03-19 bad-data
Reported results 2016-000878-38 Efficacy and Safety of Fast-acting Insulin Aspart Compared to NovoRapid® both in Combination with Insulin Degludec with or without Metformin in Adults with Type 2 Diabetes 2019-01-29 due-trials
Reported results 2016-000904-27 Efficacy and safety of semaglutide once-weekly versus placebo as add on to SGLT-2i in subjects with type 2 diabetes mellitus. A 30-week randomised, double-blind, placebo-controlled trial 2018-08-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2016-000988-16 Efficacy and Safety of Oral Semaglutide versus Placebo in Subjects with Type 2 Diabetes Mellitus treated with insulin - 52-week, randomised, double-blind, placebo-controlled trial 2018-08-22 bad-data
Reported results 2016-000989-35 Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes 2018-11-16 due-trials
Exempt, with results 2016-002396-99 Safety, tolerability, and pharmacokinetics study of single and multiple subcutaneous doses of turoctocog alfa pegol in patients with haemophilia A 2018-10-15 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2016-002801-20 A trial comparing the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without oral a... 2019-03-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2016-003821-40 Evaluation of safety following Immune Tolerance Induction treatment with turoctocog alfa in patients with haemophilia A following inhibitor development in NN7170-4213 trial 2019-06-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2016-004965-22 Efficacy and safety of semaglutide 1.0 mg once-weekly versus liraglutide 1.2 mg once-daily as add-on to 1-3 oral anti-diabetic drugs (OADs) in subjects with type 2 diabetes 2018-08-13 bad-data
Ongoing 2017-000048-17 A trial comparing the effect and safety of insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes. not-yet-due
Trial is outside EEC, and reported results 2017-000914-47 A long-term, multi-centre, randomised, controlled, double-blind, parallel-group trial, investigating the efficacy and safety of two doses of NN-220 in subjects with short stature born small for gestat... bad-data
Exempt, with results 2017-002014-31 A trial comparing the pharmacokinetic properties of fast-acting insulin aspart between children, adolescents and adults with type 1 diabetes 2018-07-05 not-yet-due
Trial is outside EEC, and reported results 2017-002281-46 Safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with moderate or severe Haemophilia A in India. bad-data
Ongoing 2017-003219-20 Effect of semaglutide once-weekly versus insulin aspart three times daily, both as add on to metformin and optimised insulin glargine (U100) in subjects with type 2 diabetes not-yet-due
Ongoing 2017-003380-35 SELECT - Semaglutide effects on cardiovascular outcomes in people with overweight or obesity not-yet-due
Listed as ongoing, but also has a completion date 2017-003414-10 Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity and type 2 diabetes 2020-05-01 bad-data
Listed as ongoing, but also has a completion date 2017-003436-36 Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity 2020-04-19 bad-data
Listed as ongoing, but also has a completion date 2017-003473-34 Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity who have reached target dose during run-in period 2020-03-20 bad-data
Ongoing 2017-003619-20 Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes not-yet-due
Ongoing 2017-003726-32 Two-year effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity not-yet-due
Ongoing 2017-003788-36 Safety and Efficacy of turoctocog alfa pegol (N8-GP) in Prophylaxis and Treatment of Bleeds in Previously N8-GP Treated Patients with Severe Haemophilia A not-yet-due
Completed, report not yet due 2017-004047-20 A randomised, cross-over, open-label, multi-centre trial comparing the effect of insulin degludec and insulin glargine 100U/mL, with or without OADs in subjects with type 2 diabetes using flash glucos... 2019-12-27 not-yet-due
Other 2018-000231-27 A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® in children with growth hormone deficiency not-yet-due
Ongoing 2018-000232-10 A dose-finding trial evaluating the effect and safety of once-weekly treatment of somapacitan compared to daily Norditropin® in children with short stature born small for gestational age with no catch... not-yet-due
Completed, report not yet due 2018-000322-63 An investigational trial comparing the efficacy and safety of once weekly NNC0148-0287 C (insulin 287) versus once daily insulin glargine, both in combination with metformin, with or without DPP-4 inh... 2020-01-17 not-yet-due
Trial is outside EEC, and reported results 2018-000750-22 A trial investigating the long-term efficacy and safety of two doses of NN-220 (somatropin [genetical recombination]) in short stature due to Noonan syndrome bad-data
Ongoing 2018-001945-14 Investigation of safety and efficacy of NNC0174-0833 for weight management – a dose finding trial not-yet-due
Ongoing 2018-002431-18 Effect and safety of semaglutide 2.4 mg once weekly on weight management in adolescents with overweight or obesity not-yet-due
Ongoing 2018-002589-38 PIONEER 12 China multi-regional clinical trial: Efficacy and safety of oral semaglutide versus sitagliptin in subjects with type 2 diabetes mellitus treated with metformin not-yet-due
Ongoing 2018-002590-22 China multi-regional clinical trial: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes mellitus treated with diet and exercise only not-yet-due
Ongoing 2018-002878-50 Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease not-yet-due
Other 2018-002952-34 Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes not-yet-due
Ongoing 2018-003141-42 Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes not-yet-due
Completed, report not yet due 2018-003406-11 A trial comparing NNC0148-0287 C (insulin 287) versus insulin glargine U100, both in combination with metformin, with or without DPP4 inhibitors and with or without SGLT2 inhibitors, in insulin-naïve ... 2020-01-17 not-yet-due
Completed, report not yet due 2018-003407-18 A trial comparing NNC0148-0287 C (insulin 287) versus insulin glargine U100, both in combination with metformin, with or without DPP4 inhibitors and with or without SGLT2 inhibitors, in basal insulin ... 2020-01-27 not-yet-due
Ongoing 2018-004484-31 Investigation of efficacy and safety of semaglutide s.c. once-weekly versus placebo in subjects with non-alcoholic steatohepatitis and compensated liver cirrhosis not-yet-due
Ongoing 2018-004529-96 Efficacy and safety of semaglutide 2.0 mg s.c. once-weekly compared to semaglutide 1.0 mg s.c. once-weekly in subjects with type 2 diabetes not-yet-due
Other 2018-004889-34 Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors not-yet-due
Other 2018-004891-36 Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B without inhibitors not-yet-due
Exempt 2019-000465-20 Safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple subcutaneous doses of NNC0365-3769 (Mim8) in healthy subjects and in subjects with haemophilia A with or without fact... not-yet-due
Completed, reported early 2019-002284-10 A TRIAL TO COMPARE THE INJECTION SITE EXPERIENCE OF 0.25 MG SEMAGLUTIDE SC ADMINISTERED BY 2 DIFFERENT PRODUCTS 2019-10-08 not-yet-due
Completed, reported early Terminated 2019-002641-37 Efficacy and safety of once-weekly subcutaneous administration of concizumab prophylaxis in patients with haemophilia A and B, with or without inhibitors 2020-03-26 not-yet-due
Ongoing 2019-003399-38 Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease not-yet-due
Completed, report not yet due 2019-003654-83 A TRIAL TO COMPARE THE INJECTION SITE PAIN EXPERIENCE OF 0.25 MG SEMAGLUTIDE B AND SEMAGLUTIDE D ADMINISTERED SC 2020-01-04 not-yet-due
Completed, report not yet due 2019-003844-57 A TRIAL TO COMPARE THE INJECTION SITE PAIN EXPERIENCE OF SEMAGLUTIDE 0.25 MG AND DULAGLUTIDE 0.75 MG ADMINISTERED SC 2020-02-26 not-yet-due
Completed, report not yet due Terminated 2019-004234-42 Effect and safety of two different dose-escalation regimens for once-weekly semaglutide s.c. in subjects with type 2 diabetes mellitus previously treated with GLP-1 RAs 2020-06-24 not-yet-due